ACE inhibitors and chronotherapy

Clinical and Experimental Hypertension

Volumn 27, Issue 2-3, 2005, Pages 179-185

  Ohmori, Masami ^a   Fujimura, Akio ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

ACE inhibitors; Blood pressure; Cardiac hypertrophy; Chronotherapy; Drug induced dry cough; Primary endpoint; Surrogate endpoint

Indexed keywords

ANESTHETIC AGENT; ANTIHISTAMINIC AGENT; ANTITUSSIVE AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOXAZOSIN; ENALAPRIL; NONSTEROID ANTIINFLAMMATORY AGENT; THEOPHYLLINE; TRANDOLAPRIL;

ANGIONEUROTIC EDEMA; CARDIOVASCULAR DISEASE; CHRONOTHERAPY; CIRCADIAN HYPERAMPLITUDE TENSION; CIRCADIAN RHYTHM; CONFERENCE PAPER; COUGHING; DISEASE SEVERITY; DOSE TIME EFFECT RELATION; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG SAFETY; HEART FAILURE; HEART HYPERTROPHY; HUMAN; HYPERTENSION; PHARMACODYNAMICS; PHARMACOKINETICS; SPONTANEOUSLY HYPERTENSIVE RAT;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; BLOOD PRESSURE; CHRONOTHERAPY; HEART FAILURE, CONGESTIVE; HUMANS; HYPERTENSION;

EID: 16444377154     PISSN: 10641963     EISSN: None     Source Type: Journal    
DOI: 10.1081/CEH-200048762     Document Type: Conference Paper

References (32)

1. Smolensky MH, Haus E. Circadian rhythms and clinical medicine with application to hypertension. Am J Hypertens 2001; 14:280-290.
2. D'Alonzo GE, Crocetti JG, Smolensky MH. Circadian rhythms in the pharmacokinetics and clinical effects of beta-agonist, theophylline, and anticholinergic medications in the treatment of nocturnal asthma. Chronobiol Int 1999; 16(5):663-682.
3. Levi F, Zidani R, Misset JL. Randomized multicentre trial of chronotherapy with oxaliplatin, fluorouracil, and folinic acid in metastatic colorectal cancer. International Organization for Cancer Chronotherapy. Lancet 1997; 350:681-686.
4. Jamali F, Thomson AB, Kirdeikis P, Tavernini M, Zuk L, Marriage B, Simpson I, Mahachai V. Diurnal variation in the pharmacokinetics of nizatidine in healthy volunteers and in patients with peptic ulcer disease. J Clin Pharmacol 1995; 35(11):1071-1075.
5. 3 in hemodialysis patients with secondary hyperparathyroidism: a single-dose study. Clin Pharmacol Ther 1999; 66(6):609-616.
6. Fujimura A, Ohashi K, Ebihara A. Time-dependent change in the effect of probucol in subjects with elevated cholesterol. Eur J Clin Pharmacol 1992; 43(3):299-301.
7. Smolensky MH, Portaluppi F. Chronopharmacology and chronotherapy of cardiovascular medications: relevance to prevention and treatment of coronary heart disease. Am Heart J 1999; 137:14-24.
8. Parmley WW, Nesto RW, Singh BN, Deanfield J, Gottlieb SO. Attenuation of the circadian patterns of myocardia ischemia with nifedipine GITS in patients with chronic stable angina. J Am Coll Cardiol 1992; 19(7):1380-1389.
9. Willich SN, Linderer T, Wegscheider K, Leizorovicz A, Alamercery I, Schroder R. Increased morning incidence of myocardial infarction in the ISAM study: absence with prior β-adrenergic blockade. Circulation 1989; 80(4):853-858.
10. Shimada K, Kawamoto A, Matsubayashi K, Nishinaga M, Kimura S, Ozawa T. Diurnal blood pressure variations and silent cerebrovascular damage in elderly patients with hypertension. J Hypertens 1992; 10(8):875-878.
11. Verdecchia P, Schillaci G, Guerrieri M, Gatteschi C, Benemio G, Boldrini F, Porcellati C. Circadian blood pressure changes and left ventricular hypertrophy in essential hypertension. Circulation 1990; 81(2):528-536.
12. Bianchi S, Bigazzi R, Baldari G, Sgherri G, Campese VM. Diurnal variations of blood pressure and microalbuminuria in essential hypertension. Am J Hypertens 1994; 7(1):23-29.
13. Kario K, Pickering TG, Umeda Y, Hoshide S, Hoshide Y, Morinari M, Murata M, Kuroda T, Schwartz JE, Shimada K. Morning surge in blood pressure as a predictor of silent and clinical cerebrovascular disease in elderly hypertensives. Circulation 2003; 107(10):1401-1406.
14. Otsuka K, Cornélissen G, Halberg F. Predictive value of blood pressure dipping and swinging with regard to vascular disease risk. Clin Drug Invest 1996; 11:20-31.
15. Pickering TG, Levenstein M, Walmsley P. Nighttime dosing of doxazosin has peak effect on morning ambulatory blood pressure. Results of the HALT Study. Hypertension and Lipid Trial Study Group. Am J Hypertens 1994; 7(9):844-847.
16. Black HR, Elliott WJ, Grandits G, Grambsch P, Lucente T, White WB, Neaton JD, Grimm RH Jr, Hansson L, Lacourciere Y, Muller J, Sleight P, Weber MA, Williams G, Wittes J, Zanchetti A, Anders RJ. Principal results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) trial. JAMA 2003; 289(16):2073-2082.
17. Song JC, White CM. Clinical pharmacokinetics and selective pharmacodynamics of new anigiotensin converting enzyme inhibitors. Clin Pharmacokinet 2002; 41(3):207-224.
18. Lemmer B. Relevance of chronopharmacology in practical medicine. Semin Perinatol 2000; 24(4):280-290.
19. Witte K, Weisser K, Neubeck M, Mutschler E, Lehmann K, Hopf R, Lemmer B. Cardiovascular effects, pharmacokinetics, and converting enzyme inhibition of enalapril after morning versus evening administration. Clin Pharmacol Ther 1993; 54:177-186.
20. Blood Pressure Lowering Treatment Trialists' Collaboration. Effects of different blood pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomized trials. Lancet 2003; 362:1527-1535.
21. Sugimoto K, Ohmori M, Kawaguchi A, Tsuruoka S, Fujimura A. Dosing time-dependent effect of trandolapril on the prevention of cardiac hypertrophy in rats with aortic banding. Jpn J Pharmacol 2001; 87:86-89.
22. Overlack A. ACE inhibitor-induced cough and branchospasm. Drug Safety 1996; 15(1):72-78.
23. Luque CA, Ortiz MV. Treatment of ACE inhibitor-induced cough. Pharmacotherapy 1999; 19(7):804-810.
24. Woo KS, Noris RM, Nicholls G. Racial difference in incidence of cough with anigiotensin-converting enzyme inhibitors (a tale of two cities). Am J Cardiol 1995; 75(1):967-968.
25. Sunaga K, Fujimura A, Shiga T, Ebihara A. Chronopharmacology of enalapril in hypertensive patients. Eur J Clin Pharmacol 1995; 48:441-445.
26. Fujimura A, Ebihara A, Shiigai T, Shimada K, Tagawa H, Gomi T, Nakamura Y, Suzuki M, Yokozuka H. Amelioration of enalapril-induced dry cough by changing dosing time from morning to evening; a preliminary trial. Jpn J Clin Pharmacol Ther 1999; 30(5):741-744.
27. Jones JK, Gorkin L, Lian JF, Staffa JA, Fletcher AP. Discontinuation of and changes in treatment after start of new course of antihypertensive drugs: a study of a United Kingdom population. BMJ 1994; 311(29):293-295.
28. Grégorie J-P. Choice of initial antihypertensive medication and continuation of use. Can J Cardiol 1999; 15(suppl F):39-41.
29. Ohmori M, Kumagai Y, Harada K, Sunaga K, Fujimura A. Administration-time dependent change in the effect of a calcium antagonist, efonidipine in a hypertensive patient with a non-dipper pattern of blood pressure. Ther Res 1995; 16(2):273-275.
30. Kario T, Matsuo T, Kobayashi H, Imiya M, Matsuo M, Shimada K. Nocturnal fall of blood pressure and silent cerebrovascular damage in elderly hypertensive patients. Advanced silent cerebrovascular damage in extreme dippers. Hypertension 1996; 27(1):130-135.
31. Imai Y, Ohkubo T, Tsuji I, Satoh H, Hisamichi S. Clinical significance of nocturnal blood pressure monitoring. Clin Exp Hypertens 1999; 21(5-6):717-727.
32. Arakawa M, Sasaki M, Ohmori M, Harada K, Fujimura A. Pharmacokinetics and pharmacodynamics of temocapril during repeated dosing in elderly hypertensive patients. Eur J Clin Pharmacol 2000; 56:775-779.